Insiders Nevro Corp.

Equities

Market Closed - Nyse Other stock markets 04:00:02 2024-06-10 pm EDT			5-day change	1st Jan Change
9.51 ^USD	+2.59%		+1.93%	-55.81%

May. 22	Citigroup Downgrades Nevro to Sell From Neutral, Adjusts Price Target to $9 From $13.50	MT
May. 14	Transcript : Nevro Corp. Presents at Bank of America Health Care Conference 2024, May-14-2024 09:20 AM

Nevro Corp. Announces Resignation of Richard B. Carter as Chief Accounting Officer and Principal Accounting Officer, Effective May 10, 2024	Apr. 25	CI
Nevro Corp. Appoints Kirt P. Karros to Board of Directors and Audit Committee of the Board	Feb. 21	CI
Insider Buy: Nevro	23-06-09	MT
Nevro Appoints Greg Siller as Chief Commercial Officer; Lowers Q2 Revenue Guidance	23-06-05	MT
Nevro Corp. Announces Executive Changes	23-06-05	CI
Nevro Appoints Kevin Thornal as Chief Executive; Reports Higher Preliminary Q1 Revenue	23-04-20	MT
Nevro Corp. Announces Board Changes	23-04-19	CI
Nevro Corp. Announces CEO Changes	23-04-19	CI
Nevro Named to 2023 Bloomberg Gender-Equality Index for Second Consecutive Year	23-01-31	PR
Nevro Reports Preliminary Q4, Full-Year Results; Issues 2023 Outlook; CEO to Retire	23-01-09	MT
Nevro Corp. Announces D. Keith Grossman to Retire as CEO, in 2023	23-01-09	CI
Nevro Corp. Announces Retirement of D. Keith Grossman as President	23-01-09	CI
Nevro Corp. Announces Executive Changes	22-09-09	CI
Nevro Corp. Announces Vale Will Not Stand for Reelection When His Current Term Expires on the Date of the Annual Meeting	22-04-11	CI
Insider Buy: Nevro	22-03-09	MT
Nevro Named to 2022 Bloomberg Gender-Equality Index	22-01-26	PR
Insider Buy: Nevro	21-11-15	MT
Nevro Corp. Appoints Sri Kosaraju as Member of the Board of Directors	21-08-31	CI
Insider Trends: 90-Days of Insider Selling at Nevro Eased Back with Share Purchase	21-08-17	MT
Insider Trends: Insider 90-Day Selling Trend Extended at Nevro	21-06-24	MT

No results for this search